A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Simple Search

You could also try: testing (1000), conducting tests (149)

BRC Research-imaging-proposal-form_v1 FINAL 10.12.2024

Description
BRC Research Imaging Proposal form The BRC Research Imaging Proposal form should be completed by the chief/principal investigator of an
Url
/Media/Southampton-Clinical-Research/Grants/Download/BRC-Research-imaging-proposal-form-v1-FINAL-10.12.2024.docx

BRC Research-imaging-proposal-form_v1 FINAL 10.12.2024

Description
BRC Research Imaging Proposal form The BRC Research Imaging Proposal form should be completed by the chief/principal investigator of an
Url
/Media/Southampton-Clinical-Research/Downloads/BRC-Research-imaging-proposal-form-v1-FINAL-10.12.2024.docx

Application for CORE Support - Version 3 18-01-2023 corrected

Description
Application for CORE Support Instructions: Please complete this form in full and submit by email to Jess Boxall or another member
Url
/Media/Southampton-Clinical-Research/Downloads/Application-for-CORE-Support-Version-3-18-01-2023-corrected.docx

Bevacizumab (7.5mgkg), Carboplatin(AUC5) and Paclitaxel (21 day)

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER BEVACIZUMAB (7.5)-CARBOPLATIN (AUC5)-PACLITAXEL (21 day) Regimen • Ovary-Bevacizumab (7.5)-Carboplatin (AUC5)-Paclitaxel (21
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Bevacizumab7.5mgkgCarboplatinandPaclitaxel21day.pdf

Ipilimumab(1mg/kg)-Nivolumab(3mg/kg)

Description
Chemotherapy Protocol RENAL CANCER IPILIMUMAB (1mg/kg)-NIVOLUMAB(3mg/kg) Regimen • Renal – Ipilimumab (1mg/kg)-Nivolumab (3mg/kg) Indication • Ipilimumab in
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Renal-cell/Ipilimumab1mgkg-Nivolumab3mgkg.pdf

RCHOP(21)-Cyclophosphamide-Doxorubicin-Prednisolone-Rituximab-Vincristine (21) Ver 1.2

Description
Chemotherapy Protocol LYMPHOMA CYCLOPHOSPHAMIDE-DOXORUBICIN-PREDNISOLONE-RITUXIMAB-VINCRISTINE (21) (RCHOP 21) There are multiple versions of this protocol in use. Please
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/RCHOP21-Cyclophosphamide-Doxorubicin-Prednisolone-Rituximab-Vincristine-21-Ver-1.2.pdf

RCHOP(14)-Cyclophosphamide-Doxorubicin-Prednisolone-Rituximab-Vincristine (14) Ver 1.2

Description
Chemotherapy Protocol LYMPHOMA CYCLOPHOSPHAMIDE-DOXORUBICIN-PREDNISOLONE-RITUXIMAB-VINCRISTINE- (14) (RCHOP 14) There are multiple versions of this protocol in use. Please
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/RCHOP14-Cyclophosphamide-Doxorubicin-Prednisolone-Rituximab-Vincristine-14-Ver-1.2.pdf

Lenalidomide-RituximabIV/SC

Description
Chemotherapy Protocol LYMPHOMA LENALIDOMIDE-RITUXIMAB (IV/SC) There are multiple versions of this protocol in use. Please ensure you have the
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Lenalidomide-RituximabIVSC.pdf

Bendamustine-Obinutuzumab

Description
Chemotherapy Protocol Non-Hodgkin Lymphoma Bendamustine-Obinutuzumab Regimen • NHL – Bendamustine-Obinutuzumab Indication • Obinutuzumab in combination with bendamustine followed by obinutuzumab maintenance
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Bendamustine-Obinutuzumab.pdf

DVd(Twice weekly)Daratumumab-Bortezomib-Dexamethasone Cycle 9 onwards

Description
Chemotherapy Protocol Myeloma Bortezomib (twice weekly) Daratumumab Dexamethasone Cycles 9 onwards Regimen • Myeloma – Bortezomib (twice weekly) with daratumumab and dexamethasone Note
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/DVdTwice-weeklyDaratumumab-Bortezomib-Dexamethasone-Cycle-9-onwards.pdf
231 to 240 of 517
Previous … 22 23 24 25 26 … Next